Concomitant medical products: product id neu_unknown_cath lot# serial# unknown implanted: explanted: product type catheter section d information references the main component of the system.Other relevant device(s) are: product id: neu_unknown_cath, serial/lot #: unknown, ubd: , udi#: medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Information was received from a healthcare provider (hcp) regarding a patient receiving unknown medication.It was reported that during a catheter revision the catheter was found adhered to the dura.The hcp requested a literature search on adhesion of intrathecal catheters to dura.No further information was reported.Additional information was received from a healthcare provider (hcp) who reported that the cause of the initial catheter revision was the patient developed bilateral hemiparesis with paralysis.During catheter revision, a granuloma formation was noted at the tip of the catheter along with the catheter adhering to the dura.The granuloma was removed along with the pump and catheter and the patient¿s symptoms had resolved.The hcp noted there was no device issue with the pump or catheter, only the granuloma formation with the catheter adhering to the dura.The cause of the catheter adhering to the dura was not known.The hcp reported that he would call back at a later time with patient identifying information and device serial/lot number along with any further information he had not reported previously.
|